Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Metagenomi Therapeutics, Inc. | 42 000 | déclaré | 02 sept. 2025 | tx 1+42 000 |
| ALNYLAM PHARMACEUTICALS, INC. | 18 103 | déclaré | 31 déc. 2014 | tx 54+590 689−183 082 |
| KalVista Pharmaceuticals, Inc. | 17 000 | déclaré | 23 nov. 2024 | tx 1+17 000 |
| Decibel Therapeutics, Inc. | 0 | déclaré | 25 sept. 2023 | tx 8+464 500−1 552 888 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 02 sept. 2025 | GRANT_AWARD | Metagenomi Therapeutics, Inc. | 42 000 | 0.00 USD | deriv |
| 23 nov. 2024 | GRANT_AWARD | KalVista Pharmaceuticals, Inc. | 17 000 | 0.00 USD | deriv |
| 25 sept. 2023 | OTHER | Decibel Therapeutics, Inc. | 220 849 | — | |
| 25 sept. 2023 | OTHER | Decibel Therapeutics, Inc. | 1 072 539 | — | deriv |
| 25 sept. 2023 | OTHER | Decibel Therapeutics, Inc. | 187 500 | — | deriv |
| 25 sept. 2023 | OTHER | Decibel Therapeutics, Inc. | 72 000 | — | deriv |
| 16 mars 2023 | GRANT_AWARD | Decibel Therapeutics, Inc. | 195 000 | 0.00 USD | |
| 16 mars 2023 | GRANT_AWARD | Decibel Therapeutics, Inc. | 72 000 | 0.00 USD | deriv |
| 25 févr. 2022 | GRANT_AWARD | Decibel Therapeutics, Inc. | 187 500 | 0.00 USD | deriv |
| 15 sept. 2021 | PURCHASE | Decibel Therapeutics, Inc. | 10 000 | 7.64 USD | 1er après silence |
| 31 déc. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 17 000 | 15.99 USD | |
| 31 déc. 2014 | TAX_WITHHOLDING | ALNYLAM PHARMACEUTICALS, INC. | 2 802 | 97.00 USD | |
| 31 déc. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 17 000 | 0.00 USD | deriv |
| 12 déc. 2014 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 6 667 | 0.00 USD | deriv |
| 18 nov. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 2 500 | 7.10 USD | |
| 18 nov. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3 861 | 9.14 USD | |
| 18 nov. 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 102 | 91.79 USD | anomalie |
| 18 nov. 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 5 413 | 90.30 USD | |
| 18 nov. 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 4 485 | 91.08 USD | |
| 18 nov. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3 639 | 15.99 USD | |
| 18 nov. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3 861 | 0.00 USD | deriv |
| 18 nov. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 2 500 | 0.00 USD | deriv |
| 18 nov. 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 3 639 | 0.00 USD | deriv |
| 18 août 2014 | EXERCISE | ALNYLAM PHARMACEUTICALS, INC. | 11 000 | 9.14 USD | |
| 18 août 2014 | SALE | ALNYLAM PHARMACEUTICALS, INC. | 7 000 | 67.80 USD |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 15 sept. 2021.